• Biopharma firm Radius Health is going private in an $890M M&A deal

    8 days ago - By MedCity News

    Two private equity firms have reached an $890 million deal to buy Radius Health, a company whose main asset is the commercialized osteoporosis drug Tymlos. In other M&A news, cancer biotech F-star Therapeutics is being acquired in a $161 million deal.
    Read more ...